Skip to content

Nhân Chứng Giê-hô-va

Chọn ngôn ngữ Việt

Khoa ung thư

Xử lý bệnh giảm tiểu cầu

Autologous stem cell transplantation in patients who object to a blood transfusion: contribution of new pharmacological haematopoiesis support.

Al-Nawakil C, Quarre MC, Heshmati F, Deau B, Park S, Dreyfus F, Bouscary D, Tamburini J.

Nguồn‎: Br J Haematol 2013;161(5):738-40.

Mã bài‎: PubMed 23480574

DOI‎: 10.1111/bjh.12284

https://www.ncbi.nlm.nih.gov/pubmed/23480574

The effect of interleukin 11 on thrombocytopenia associated with tyrosine kinase inhibitor therapy in patients with chronic myeloid leukemia.

Aribi A, Kantarjian H, Koller C, Thomas D, Faderl S, Garcia-Manero G, Cortes J.

Nguồn‎: Cancer 2008;113(6):1338-43.

Mã bài‎: PubMed 18629842

DOI‎: 10.1002/cncr.23718

https://www.ncbi.nlm.nih.gov/pubmed/18629842

Romiplostim efficacy in an acute myeloid leukemia patient with transfusion refractory thrombocytopenia.

Berthelot-Richer M, Boilard B, Morin A, Bolduc B, Beauregard P, Kotb R.

Nguồn‎: Transfusion 2012;52(4):739-41.

Mã bài‎: PubMed 22082044

DOI‎: 10.1111/j.1537-2995.2011.03382.x

https://www.ncbi.nlm.nih.gov/pubmed/22082044

Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide.

Chawla SP, Staddon A, Hendifar A, Messam CA, Patwardhan R, Kamel YM.

Nguồn‎: BMC Cancer 2013;13:121.

Mã bài‎: PubMed 23497336

DOI‎: 10.1186/1471-2407-13-121

https://www.ncbi.nlm.nih.gov/pubmed/23497336

Efficacy of romiplostim in the treatment of chemotherapy induced thrombocytopenia (CIT) in a patient with mantle cell lymphoma.

Demeter J, Istenes I, Fodor A, Paksi M, Dombi P, Valasinyószki E, Csomor J, Matolcsy A, Nagy ZG.

Nguồn‎: Pathol Oncol Res 2011;17(1):141-3.

Mã bài‎: PubMed 20628840

DOI‎: 10.1007/s12253-010-9276-4

https://www.ncbi.nlm.nih.gov/pubmed/20628840

Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient.

Duic JP, Grewal J, McConie K, Staszewski H, Haas J, Kesari S.

Nguồn‎: J Neurooncol 2012;106(2):427-9.

Mã bài‎: PubMed 21833801

DOI‎: 10.1007/s11060-011-0675-5

https://www.ncbi.nlm.nih.gov/pubmed/21833801

Recombinant human interleukin 11 and bacterial infection in patients with haematological malignant disease undergoing chemotherapy: a double-blind placebo-controlled randomised trial.

Ellis M, Zwaan F, Hedström U, Poynton C, Kristensen J, Jumaa P, Wassell J, al-Ramadi B.

Nguồn‎: Lancet 2003;361(9354):275-80.

Mã bài‎: PubMed 12559860

https://www.ncbi.nlm.nih.gov/pubmed/12559860

Autologous stem-cell transplantation without hematopoietic support for the treatment of hematologic malignancies in Jehovah's Witnesses.

Ford PA, Grant SJ, Mick R, Keck G.

Nguồn‎: J Clin Oncol 2015;33(15):1674-9.

Mã bài‎: PubMed 25870085

DOI‎: 10.1200/JCO.2014.57.9912

https://www.ncbi.nlm.nih.gov/pubmed/25870085

Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1-risk myelodysplastic syndrome and thrombocytopenia.

Giagounidis A, Mufti GJ, Fenaux P, Sekeres MA, Szer J, Platzbecker U, Kuendgen A, Gaidano G, Wiktor-Jedrzejczak W, Hu K, Woodard P, Yang AS, Kantarjian HM.

Nguồn‎: Cancer 2014;120(12):1838-46.

Mã bài‎: PubMed 24706489

DOI‎: 10.1002/cncr.28663

https://www.ncbi.nlm.nih.gov/pubmed/24706489

A randomized controlled trial of romiplostim in patients with low- or intermediate-risk myelodysplastic syndrome receiving decitabine.

Greenberg PL, Garcia-Manero G, Moore M, Damon L, Roboz G, Hu K, Yang AS, Franklin J.

Nguồn‎: Leuk Lymphoma 2013;54(2):321-8.

Mã bài‎: PubMed 22906162

DOI‎: 10.3109/10428194.2012.713477

https://www.ncbi.nlm.nih.gov/pubmed/22906162

Thrombopoietin-receptor agonists in haematological disorders: the Danish experience.

Gudbrandsdottir S, Frederiksen H, Hasselbalch H.

Nguồn‎: Platelets 2012;23(6):423-9.

Mã bài‎: PubMed 22185370

DOI‎: 10.3109/09537104.2011.634931

https://www.ncbi.nlm.nih.gov/pubmed/22185370

Recombinant human thrombopoietin promotes platelet engraftment after haploidentical hematopoietic stem cell transplantation: a prospective randomized controlled trial.

Han TT, Xu LP, Liu DH, Liu KY, Wang FR, Wang Y, Yan CH, Chen YH, Sun YQ, Ji Y, Wang JZ, Zhang XH, Huang XJ.

Nguồn‎: Ann Hematol 2015;94(1):117-28.

Mã bài‎: PubMed 25069650

DOI‎: 10.1007/s00277-014-2158-1

https://www.ncbi.nlm.nih.gov/pubmed/25069650

The non-peptide thrombopoietin receptor agonist eltrombopag stimulates megakaryopoiesis in bone marrow cells from patients with relapsed multiple myeloma.

Jeong JY, Levine MS, Abayasekara N, Berliner N, Laubach J, Vanasse GJ.

Nguồn‎: J Hematol Oncol 2015;8:37.

Mã bài‎: PubMed 25886818

DOI‎: 10.1186/s13045-015-0136-2

https://www.ncbi.nlm.nih.gov/pubmed/25886818

Safety and efficacy of romiplostim in patients with lower-risk myelodysplastic syndrome and thrombocytopenia.

Kantarjian H, Fenaux P, Sekeres MA, Becker PS, Boruchov A, Bowen D, Hellstrom-Lindberg E, Larson RA, Lyons RM, Muus P, Shammo J, Siegel R, Hu K, Franklin J, Berger DP.

Nguồn‎: J Clin Oncol 2010;28(3):437-44.

Mã bài‎: PubMed 20008626

DOI‎: 10.1200/JCO.2009.24.7999

https://www.ncbi.nlm.nih.gov/pubmed/20008626

A single center experience with romiplostim for the management of chemotherapy-induced thrombocytopenia.

Miao J, Leblebjian H, Scullion B, Parnes A

Nguồn‎: Am J Hematol 2018;93(4):E86-E88.

Mã bài‎: PubMed 29274130

DOI‎: 10.1002/ajh.25022

https://www.ncbi.nlm.nih.gov/pubmed/29274130

Pharmacological therapies to minimise platelet transfusion.

Norfolk DR, Seghatchian J.

Nguồn‎: Transfus Sci 2000;22(3):149-53.

Mã bài‎: PubMed 10831916

https://www.ncbi.nlm.nih.gov/pubmed/10831916

Romiplostim for management of chemotherapy-induced thrombocytopenia.

Parameswaran R, Lunning M, Mantha S, Devlin S, Hamilton A, Schwartz G, Soff G.

Nguồn‎: Support Care Cancer 2014;22(5):1217-22.

Mã bài‎: PubMed 24414994

DOI‎: 10.1007/s00520-013-2074-2

https://www.ncbi.nlm.nih.gov/pubmed/24414994

Eltrombopag for the treatment of thrombocytopenia in patients with malignant and non-malignant hematologic disorders.

Pathak S, Roth M, Verma A, Steidl U.

Nguồn‎: Expert Opin Drug Metab Toxicol 2013;9(12):1667-75.

Mã bài‎: PubMed 24215532

DOI‎: 10.1517/17425255.2013.858119

https://www.ncbi.nlm.nih.gov/pubmed/24215532

Safety and tolerability of eltrombopag versus placebo for treatment of thrombocytopenia in patients with advanced myelodysplastic syndromes or acute myeloid leukaemia: a multicentre, randomised, placebo-controlled, double-blind, phase 1/2 trial.

Platzbecker U, Wong RS, Verma A, Abboud C, Araujo S, Chiou TJ, Feigert J, Yeh SP, Götze K, Gorin NC, Greenberg P, Kambhampati S, Kim YJ, Lee JH, Lyons R, Ruggeri M, Santini V, Cheng G, Jang JH, Chen CY, Johnson B, Bennett J, Mannino F, Kamel YM, Stone N, Dougherty S, Chan G, Giagounidis A.

Nguồn‎: Lancet Haematol 2015;2(10):e417-26.

Mã bài‎: PubMed 26686043

https://www.ncbi.nlm.nih.gov/pubmed/26686043

Romiplostim for delayed platelet recovery and secondary thrombocytopenia following allogeneic stem cell transplantation.

Poon LM, Di Stasi A, Popat U, Champlin RE, Ciurea SO.

Nguồn‎: Am J Blood Res 2013;3(3):260-4.

Mã bài‎: PubMed 23997988

https://www.ncbi.nlm.nih.gov/pubmed/23997988

Safety and efficacy of eltrombopag in post-hematopoietic stem cell transplantation (HSCT) thrombocytopenia.

Raut SS, Shah SA, Sharanangat VV, Shah KM, Patel KA, Anand AS, Talati SS, Panchal HP, Patel AA, Parikh SK, Shukla SN.

Nguồn‎: Indian J Hematol Blood Transfus 2015;31(4):413-5.

Mã bài‎: PubMed 26306064

DOI‎: 10.1007/s12288-014-0491-0

https://www.ncbi.nlm.nih.gov/pubmed/26306064

Identifying drugs that cause acute thrombocytopenia: an analysis using 3 distinct methods.

Reese JA, Li X, Hauben M, Aster RH, Bougie DW, Curtis BR, George JN, Vesely SK.

Nguồn‎: Blood 2010;116(12):2127-33.

Mã bài‎: PubMed 20530792

DOI‎: 10.1182/blood-2010-03-276691

https://www.ncbi.nlm.nih.gov/pubmed/20530792

Eltrombopag inhibits the proliferation of leukemia cells via reduction of intracellular iron and induction of differentiation.

Roth M, Will B, Simkin G, Narayanagari S, Barreyro L, Bartholdy B, Tamari R, Mitsiades CS, Verma A, Steidl U.

Nguồn‎: Blood 2012;120(2):386-94.

Mã bài‎: PubMed 22627766

DOI‎: 10.1182/blood-2011-12-399667

https://www.ncbi.nlm.nih.gov/pubmed/22627766

Subcutaneous or intravenous administration of romiplostim in thrombocytopenic patients with lower risk myelodysplastic syndromes.

Sekeres MA, Kantarjian H, Fenaux P, Becker P, Boruchov A, Guerci-Bresler A, Hu K, Franklin J, Wang YM, Berger D.

Nguồn‎: Cancer 2011;117(5):992-1000.

Mã bài‎: PubMed 20945323

DOI‎: 10.1002/cncr.25545

https://www.ncbi.nlm.nih.gov/pubmed/20945323

Effects of erythropoietin on platelet reactivity and thrombopoiesis in humans.

Stohlawetz PJ, Dzirlo L, Hergovich N, Lackner E, Mensik C, Eichler HG, Kabrna E, Geissler K, Jilma B.

Nguồn‎: Blood 2000;95(9):2983-9.

Mã bài‎: PubMed 10779449

https://www.ncbi.nlm.nih.gov/pubmed/10779449

A pilot phase I dose finding safety study of the thrombopoietin-receptor agonist, eltrombopag, in patients with myelodysplastic syndrome treated with azacitidine.

Svensson T, Chowdhury O, Garelius H, Lorenz F, Saft L, Jacobsen SE, Hellström-Lindberg E, Cherif H.

Nguồn‎: Eur J Haematol 2014;93(5):439-45.

Mã bài‎: PubMed 24853277

DOI‎: 10.1111/ejh.12383

https://www.ncbi.nlm.nih.gov/pubmed/24853277

Eltrombopag for treatment of thrombocytopenia after allogeneic hematopoietic cell transplantation.

Tanaka T, Inamoto Y, Yamashita T, Fuji S, Okinaka K, Kurosawa S, Kim SW, Tanosaki R, Fukuda T.

Nguồn‎: Biol Blood Marrow Transplant 2016;22(5):919-24.

Mã bài‎: PubMed 26785333

DOI‎: 10.1016/j.bbmt.2016.01.018

https://www.ncbi.nlm.nih.gov/pubmed/26785333

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Nguồn‎: Ann Oncol 2005;16(1):139-45.

Mã bài‎: PubMed 15598951

DOI‎: 10.1093/annonc/mdi007

https://www.ncbi.nlm.nih.gov/pubmed/15598951

A randomized, double-blind, placebo-controlled phase 2 study evaluating the efficacy and safety of romiplostim treatment of patients with low or intermediate-1 risk myelodysplastic syndrome receiving lenalidomide.

Wang ES, Lyons RM, Larson RA, Gandhi S, Liu D, Matei C, Scott B, Hu K, Yang AS.

Nguồn‎: J Hematol Oncol 2012;5:71.

Mã bài‎: PubMed 23190430

DOI‎: 10.1186/1756-8722-5-71

https://www.ncbi.nlm.nih.gov/pubmed/23190430

Effect of the nonpeptide thrombopoietin receptor agonist eltrombopag on bone marrow cells from patients with acute myeloid leukemia and myelodysplastic syndrome.

Will B, Kawahara M, Luciano JP, Bruns I, Parekh S, Erickson-Miller CL, Aivado MA, Verma A, Steidl U.

Nguồn‎: Blood 2009;114(18):3899-908.

Mã bài‎: PubMed 19710504

DOI‎: 10.1182/blood-2009-04-219493

https://www.ncbi.nlm.nih.gov/pubmed/19710504


Phần y khoa của trang web jw.org được thiết kế nhằm cung cấp tài liệu chủ yếu cho bác sĩ và những người thuộc ngành y. Phần này không tư vấn về y khoa hoặc đề nghị bất cứ phương pháp điều trị nào, và cũng không thay thế cho bác sĩ. Tài liệu y khoa được liệt kê trong phần này không do Nhân Chứng Giê-hô-va xuất bản, nhưng bàn về những phương pháp điều trị không truyền máu mà bác sĩ có thể quyết định xem xét. Chính bác sĩ có trách nhiệm phân loại những thông tin cập nhật hơn, bàn bạc các phương cách điều trị và hỗ trợ bệnh nhân lựa chọn một cách sáng suốt dựa trên tình trạng sức khỏe, ước nguyện và niềm tin của bệnh nhân. Không phải tất cả các phương pháp được liệt kê đều thích hợp cho mọi bệnh nhân.

Đôi lời với bệnh nhân: Xin luôn hỏi ý kiến của bác sĩ về vấn đề sức khỏe và cách điều trị. Cần đi khám bác sĩ nếu cảm thấy bệnh.

Việc sử dụng trang web này được chi phối bởi các điều khoản sử dụng.